why it matters that the fda just approved the first 3d-printed drug
FDA approved 3D for the first time ever- Printed prescription drugs for consumer use. This 3D- Aprecia Pharma will sell printed pills called Spritam, which are available to more than 3 million adults and children in the United States who suffer from certain types of seizures caused by epilepsy. There are many innovations in 3D printing. Several reasons for the impact on the pharmaceutical industry. First of all, this means that we can see the 3D printing process used as part of a regular medication plan to make drugs that are easier to consume and more effective to use. \"By printing 3D technology and height According to Aprecia CEO don Wetherhold, Spritam is designed to meet the needs of patients who struggle with current drug treatment experience. Since Aprecia\'s proprietary 3D printing process is known as the ZipDose technology platform, the physical composition of the Spritam pill can become more porous than the typical pill, which means that when liquid is added, it dissolves almost instantly. Just take a sip of water or other liquid and it will melt in your mouth, making it easier to swallow. Aprecia refers to these new 3D- Print as \"fast- Distinguish them from tablets and capsules. In addition, since the active ingredients are added via a 3D printer, Aprecia Pharma is able to provide a high dose of up to 1,000 mg and knows that each dose will be exactly the same. This means that we will soon be able to see the introduction of custom drugs and drugs customized for specific patients and users-no longer custom drugs and drugssize- Suitable for all drug treatments. With 3D printing, each dose can be measured separately and then printed. Later, this development could lead to the biggest breakthrough-a structural shift in the way patients and doctors think about medicine. In the 2012 TED presentation, Lee Cronin of the University of Glasgow described a new 3D printing method that could allow patients to print their own medicines at home. What is needed, he explained, is a general set of \"chemical inks\" and a way to print laboratory instruments and these chemical inks in 3D at the same time. Essentially, this will enable 3D printers to catalyse chemical reactions in order to print drugs when needed. Therefore, the pharmaceutical industry may eventually experience a shift from prescription to algorithm. The doctor can give up an algorithm for the patient to print on a 3D printer at home instead of writing down on paper \"call me in the morning with 2 \". These algorithms will include information on a set of chemical inks needed to print a drug, as well as molecular blueprints. 3D printing can also lead to a significant shift in drug research and development, because the whole process of testing drugs becomes more efficient, so the cost is lower. While home 3D printing of drugs may not be achieved soon, 3D printing of sample tissues and organs may be possible for drug testing purposes. Imagine testing drugs on 3D human organs instead of on animals or synthetic models. 3D printing may allow new compounds and drugs based on new geometric shapes and configurations that 3D printing may achieve. Of course, the big wildcard for all this is the FDA approval process. Yes, it\'s also a long process that the FDA can sometimes be accused of bringing new drugs to market quickly and effectively. Adding to the \"gee wh\" aspect of 3D printing, it\'s easy to see other potential regulatory nightmares approved by the FDA. However, the FDA appears to be very open to the idea of 3D printing, although it acknowledges that regulatory barriers may be significant. Even before the approval of the 3D printing pill, the agency has approved the first 3D printing prosthesis. Last year, the FDA held a 3D printing workshop for medical device manufacturers, which can be seen as an encouraging signal to continue on the same 3D printing path. Aprecia Pharma is a pioneer in 3D concepts Printed pills, which have obtained more than 50 patents related to 3D printing drug applications, and promise to bring new nerve drugs to market through 3D printing. As Don Wetherhold, CEO of Aprecia, pointed out. \"This is the first of a range of central nervous system products that Aprecia plans to launch as part of our commitment to change the patient\'s medication experience. \"We may never give up the need for corner pharmacies to fill out prescriptions, but a 3D printer may fundamentally change the way patients take certain types of drugs. 3D printers can make the world of custom medicine possible, in which patients play an active role in bringing their own custom medicine Pills designed for the market.